Privium Fund Management (UK)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Privium Fund Management (UK)’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,000	Closed	-$2.17M	–	89
2021 Q1	$2.17M	Buy	+10,000	New	+$1.88M	1.51%	16

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Privium Fund Management (UK)'s GWPH Position: Q2 2021 in Review

Privium Fund Management (UK) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 10,000 shares — an estimated $2.17M sold.

Privium Fund Management (UK) first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $2.17M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Privium Fund Management (UK) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Privium Fund Management (UK) sold 10,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $2.17M.
Privium Fund Management (UK) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Privium Fund Management (UK)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.17M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Privium Fund Management (UK)'s 13F filing for Q2 2021, filed 10 Aug 2021.